다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Tzu chi medical journal = 慈濟醫學雜誌, v.29 no.3, 2017년, pp.138 - 142
Chen, Yu-Hung (Department of Nuclear Medicine, Buddhist Tzu Chi General Hospital, Hualien, Taiwan) , Lo, Raymond Y. (Department of Neurology, Memory and Aging Center, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan)
AI-Helper
Alzheimer's disease (AD) and osteoporosis are both common degenerative diseases in the elderly population. The incidence of both diseases increases with age and will be posing enormous societal burden worldwide. It may appear that AD and osteoporosis are two distinct diseases although many risk fact...
1 Wimo A Jonsson L Bond J Prince M Winblad B Alzheimer Disease International The worldwide economic impact of dementia 2010 Alzheimers Dement 2013 9 1 11.e3 23305821
2 Brookmeyer R Evans DA Hebert L Langa KM Heeringa SG Plassman BL National estimates of the prevalence of Alzheimer's disease in the United States Alzheimers Dement 2011 7 61 73 21255744
3 Rocca WA Petersen RC Knopman DS Hebert LE Evans DA Hall KS Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States Alzheimers Dement 2011 7 80 93 21255746
4 Prince M Bryce R Albanese E Wimo A Ribeiro W Ferri CP The global prevalence of dementia: A systematic review and metaanalysis Alzheimers Dement 2013 9 63 75.e2 23305823
5 Bliuc D Nguyen ND Milch VE Nguyen TV Eisman JA Center JR Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women JAMA 2009 301 513 21 19190316
6 Bliuc D Nguyen ND Nguyen TV Eisman JA Center JR Compound risk of high mortality following osteoporotic fracture and refracture in elderly women and men J Bone Miner Res 2013 28 2317 24 23616397
7 Peters R Peters J Warner J Beckett N Bulpitt C Alcohol, dementia and cognitive decline in the elderly: A systematic review Age Ageing 2008 37 505 12 18487267
8 Tysiewicz-Dudek M Pietraszkiewicz F Drozdzowska B Alzheimer's disease and osteoporosis: Common risk factors or one condition predisposing to the other? Ortop Traumatol Rehabil 2008 10 315 23 18779764
9 Cataldo JK Prochaska JJ Glantz SA Cigarette smoking is a risk factor for Alzheimer's disease: An analysis controlling for tobacco industry affiliation J Alzheimers Dis 2010 19 465 80 20110594
10 Tan ZS Seshadri S Beiser A Zhang Y Felson D Hannan MT Bone mineral density and the risk of Alzheimer disease Arch Neurol 2005 62 107 11 15642856
11 Amouzougan A Lafaie L Marotte H D？nari？ D Collet P Pallot-Prades B High prevalence of dementia in women with osteoporosis Joint Bone Spine 2016 pii: S1297-319X(16)30139-7 doi: 10.1016/j.jbspin.2016.08.002. [Epub ahead of print]
12 Zhou R Deng J Zhang M Zhou HD Wang YJ Association between bone mineral density and the risk of Alzheimer's disease J Alzheimers Dis 2011 24 101 8 21187587
13 Chang KH Chung CJ Lin CL Sung FC Wu TN Kao CH Increased risk of dementia in patients with osteoporosis: A population-based retrospective cohort analysis Age (Dordr) 2014 36 967 75 24347180
14 Brenner DE Kukull WA Stergachis A van Belle G Bowen JD McCormick WC Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study Am J Epidemiol 1994 140 262 7 8030629
15 Depypere H Vierin A Weyers S Sieben A Alzheimer's disease, apolipoprotein E and hormone replacement therapy Maturitas 2016 94 98 105 27823753
16 Henderson VW Estrogen-containing hormone therapy and Alzheimer's disease risk: Understanding discrepant inferences from observational and experimental research Neuroscience 2006 138 1031 9 16310963
17 Wang HK Hung CM Lin SH Tai YC Lu K Liliang PC Increased risk of hip fractures in patients with dementia: A nationwide population-based study BMC Neurol 2014 14 175 25213690
18 Zhao Y Shen L Ji HF Alzheimer's disease and risk of hip fracture: A meta-analysis study Scientific World Journal 2012 2012 872173 22629218
19 Lee JH Bliwise DL Ansari FP Goldstein FC Cellar JS Lah JJ Daytime sleepiness and functional impairment in Alzheimer disease Am J Geriatr Psychiatry 2007 15 620 6 17586786
20 Nanes MS Kallen CB Osteoporosis Semin Nucl Med 2014 44 439 50 25362234
21 Loskutova N Honea RA Vidoni ED Brooks WM Burns JM Bone density and brain atrophy in early Alzheimer's disease J Alzheimers Dis 2009 18 777 85 19661621
22 Loskutova N Honea RA Brooks WM Burns JM Reduced limbic and hypothalamic volumes correlate with bone density in early Alzheimer's disease J Alzheimers Dis 2010 20 313 22 20164583
23 Scheltens P Blennow K Breteler MM de Strooper B Frisoni GB Salloway S Alzheimer's disease Lancet 2016 388 505 17 26921134
24 Vallabhajosula S Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid Semin Nucl Med 2011 41 283 99 21624562
25 Boyle WJ Simonet WS Lacey DL Osteoclast differentiation and activation Nature 2003 423 337 42 12748652
26 Nakashima T Takayanagi H New regulation mechanisms of osteoclast differentiation Ann N Y Acad Sci 2011 1240 E13 8 22360322
27 Asagiri M Takayanagi H The molecular understanding of osteoclast differentiation Bone 2007 40 251 64 17098490
28 Kular J Tickner J Chim SM Xu J An overview of the regulation of bone remodelling at the cellular level Clin Biochem 2012 45 863 73 22465238
29 Zhao Q Shao J Chen W Li YP Osteoclast differentiation and gene regulation Front Biosci 2007 12 2519 29 17127260
30 Baron R Arming the osteoclast Nat Med 2004 10 458 60 15122243
31 Cui S Xiong F Hong Y Jung JU Li XS Liu JZ APPswe/Aß regulation of osteoclast activation and RAGE expression in an age-dependent manner J Bone Miner Res 2011 26 1084 98 21542009
32 Xia WF Jung JU Shun C Xiong S Xiong L Shi XM Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit, which are ameliorated by N-acetyl-L-cysteine J Bone Miner Res 2013 28 2122 35 23649480
33 Li S Liu B Zhang L Rong L Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function Bone 2014 61 164 75 24473375
34 Li S Yang B Teguh D Zhou L Xu J Rong L Amyloid β peptide enhances RANKL-induced osteoclast activation through NF-κB, ERK, and calcium oscillation signaling Int J Mol Sci 2016 17 pii: E1683
35 Littlejohns TJ Henley WE Lang IA Annweiler C Beauchet O Chaves PH Vitamin D and the risk of dementia and Alzheimer disease Neurology 2014 83 920 8 25098535
36 Afzal S Bojesen SE Nordestgaard BG Reduced 25-hydroxyvitamin D and risk of Alzheimer's disease and vascular dementia Alzheimers Dement 2014 10 296 302 23871764
37 Shen L Ji HF Vitamin D deficiency is associated with increased risk of Alzheimer's disease and dementia: Evidence from meta-analysis Nutr J 2015 14 76 26231781
38 Annweiler C Llewellyn DJ Beauchet O Low serum Vitamin D concentrations in Alzheimer's disease: A systematic review and meta-analysis J Alzheimers Dis 2013 33 659 74 23042216
39 Mokry LE Ross S Morris JA Manousaki D Forgetta V Richards JB Genetically decreased Vitamin D and risk of Alzheimer disease Neurology 2016 87 2567 574 27856775
40 Smith GD Ebrahim S 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003 32 1 22 12689998
41 Wang TJ Zhang F Richards JB Kestenbaum B van Meurs JB Berry D Common genetic determinants of Vitamin D insufficiency: A genome-wide association study Lancet 2010 376 180 8 20541252
42 Moon M Song H Hong HJ Nam DW Cha MY Oh MS Vitamin D-binding protein interacts with aβ and suppresses aβ-mediated pathology Cell Death Differ 2013 20 630 8 23257976
43 Pozuelo-Moyano B Benito-Leon J Vitamin D and multiple sclerosis Rev Neurol 2013 56 243 51 23400652
44 Russ TC Murianni L Icaza G Slachevsky A Starr JM Geographical variation in dementia mortality in italy, new zealand, and chile: The impact of latitude, Vitamin D, and air pollution Dement Geriatr Cogn Disord 2016 42 31 41 27536986
45 Dastani Z Berger C Langsetmo L Fu L Wong BY Malik S In healthy adults, biological activity of Vitamin D, as assessed by serum PTH, is largely independent of DBP concentrations J Bone Miner Res 2014 29 494 9 23857798
46 Sevigny J Chiao P Bussiere T Weinreb PH Williams L Maier M The antibody aducanumab reduces Abeta plaques in Alzheimer's disease Nature 2016 537 50 6 27582220
47 Mallik A Drzezga A Minoshima S Clinical amyloid imaging Semin Nucl Med 2017 47 31 43 27987555
48 Law WP Wang WY Moore PT Mollee PN Ng AC Cardiac amyloid imaging with 18F-florbetaben PET: A pilot study J Nucl Med 2016 57 1733 9 27307344
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.